The beta amyloid peptide can act as a modular aggregation domain.
Although there is compelling evidence that the beta amyloid peptide (Abeta) can be centrally involved in Alzheimer's disease, the natural role (if any) of this peptide remains unclear. Here we use green fluorescent protein (GFP) fusions to demonstrate that the Abeta sequence, like prion domains, can act as a modular aggregation domain when terminally appended to a normally soluble protein. We find that a single amino acid substitution (Leu(17) to Pro) in the beta peptide sequence can abolish this cis capacity to induce aggregation. Introduction of this substitution into full-length APP (i.e., a Leu(613)Pro substitution in APP695) alters the processing of APP leading to the accumulation of the C99 C-terminal fragment (CTF). We suggest that in at least some aggregation disease-related proteins the presence of an aggregation domain is not "accidental", but reflects a selected role of these domains in modulating the trafficking or metabolism of the parental protein.
Link
Christopher D
CD
Institute for Behavioral Genetics, University of Colorado, Boulder, CO 80309, USA. linkc@colorado.edu
Fonte
Virginia
V
Roberts
Christine M
CM
Hiester
Brian
B
Silverman
Michael A
MA
Stein
Gretchen H
GH
D000595:Amino Acid Sequence; D019943:Amino Acid Substitution; D016229:Amyloid beta-Peptides / Q000737:chemistry* / Q000378:metabolism*; D000818:Animals; D019921:Biotinylation; D016466:CHO Cells; D002478:Cells, Cultured; D006224:Cricetinae; D003412:Cricetulus; D004797:Enzyme-Linked Immunosorbent Assay; D005455:Fluorescent Antibody Technique; D006801:Humans; D015151:Immunoblotting; D010446:Peptide Fragments / Q000737:chemistry* / Q000378:metabolism; D017434:Protein Structure, Tertiary; D051381:Rats; D011993:Recombinant Fusion Proteins / Q000737:chemistry / Q000378:metabolism; D020539:Sequence Analysis, Protein
D016229:Amyloid beta-Peptides; D010446:Peptide Fragments; D011993:Recombinant Fusion Proteins
J Biol Chem. 2006 Jan 20;281(3):1808-16
16239215
J Neurochem. 2007 May;101(3):854-62
17448150
J Neurochem. 1998 Oct;71(4):1616-25
9751195
FEBS Lett. 2004 Jul 16;570(1-3):73-6
15251442
Proc Natl Acad Sci U S A. 2000 May 23;97(11):5750-5
10811890
Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9368-72
7568134
J Biol Chem. 2007 Nov 30;282(48):35350-60
17890228
Science. 2000 Jan 28;287(5453):661-4
10650001
Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4697-702
11917117
J Biol Chem. 2001 Oct 26;276(43):40288-92
11544248
Cell. 2001 Jul 27;106(2):183-94
11511346
Biochem Biophys Res Commun. 2003 Jan 31;301(1):231-5
12535668
Neuron. 2003 Mar 27;37(6):925-37
12670422
Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):9989-90
10468546
J Biol Chem. 2002 Mar 1;277(9):6763-6
11744687
Neurobiol Aging. 2001 Mar-Apr;22(2):217-26
11182471
Cell. 2003 Dec 26;115(7):879-91
14697205
Exp Cell Res. 2003 Jul 1;287(1):1-9
12799176
Cell. 1998 Jun 26;93(7):1241-52
9657156
EMBO J. 2007 Mar 21;26(6):1702-12
17332749
Int J Mol Med. 2004 Jan;13(1):121-5
14654982
Mol Microbiol. 1993 Mar;7(5):683-92
8469113
Nature. 2000 Sep 28;407(6803):477-83
11028992
J Biol Chem. 2007 Jan 5;282(1):142-50
17095512
Cell. 1993 Jun 18;73(6):1055-8
8513491
J Neurosci. 2000 Jan 1;20(1):219-29
10627599
J Biol Chem. 2008 Mar 14;283(11):7271-9
18182389
PLoS Biol. 2004 Apr;2(4):E86
15045026
FASEB J. 2006 Jun;20(8):1254-6
16636103
J Mol Biol. 2002 Jun 21;319(5):1279-90
12079364
Trends Neurosci. 2002 Dec;25(12):616-20
12446128
J Neurosci. 1999 Jan 15;19(2):705-15
9880591
J Biol Chem. 2001 Sep 7;276(36):33923-9
11438549
Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1589-94
10677504